Summary
The effects of single oral doses of mequitazine (5 and 10 mg), terfenadine (60 mg) and triprolidine (10 mg) as active controls, and placebo were evaluated on visuo-motor coordination, digit symbol substitution, critical flicker fusion and dynamic visual acuity, and on subjective assessments of mood and well-being in six normal female volunteers. The study was double-blind. Mequitazine (5 mg) impaired visuo-motor coordination 7.5 h after ingestion (considered to be a chance result), but there was no effect on digit symbol substitution, critical flicker fusion threshold or dynamic visual acuity. Mequitazine (10 mg) impaired visuo-motor coordination and reduced the number of substitutions on the digit symbol substitution test. Terfenadine (60 mg) had no effect on performance or on subjective feelings. Triprolidine (10 mg) impaired visuo-motor coordination, reduced the number of substitutions on the digit symbol test, lowered the critical flicker fusion threshold and reduced dynamic visual acuity. Mequitazine (5 mg) and terfenadine (60 mg) are likely to prove acceptable H1 antagonists when sedation must be avoided.
Similar content being viewed by others
References
Borland RG, Nicholson AN (1974) Human performance after a barbiturate (heptabarbitone). Br J Clin Pharmacol 1: 209–215
Brandon ML, Weiner M (1980) Clinical investigation of terfenadine, a non-sedative antihistamine. Ann Allergy 44: 71–75
Caille EJ (1979) Etude comparative du Primalan et de la Polaramine sur l'eeg, la vigilance et la thymie. Psychologie Medicale 11: 1541–1555
Cheng HC, Reavis OK, Munro NL, Woodward JK (1977) Antihistaminic effect of terfenadine. Pharmacologist 19: 187
Clarke CH, Nicholson AN (1978) Performance studies with antihistamines. Br J Clin Pharmacol 6: 31–36
Dubuis R, Charpin J, Orlando JP, Gervais P (1978) Le traitement antihistaminique des pollinosis aigues a l'epreuve du double insu. Therapeutique 2: 137–140
Gervais P, Gervais A, de Beule R, Van de Bijl W (1975) Essai compare d'un nouvel antihistamine, la mequitazine et d'un placebo. Acta Allergol 30: 286–297
Halpern G, Sabouraud D, Garcelon M (1977) Recherche par la technique a double insu d'une diminution de vigilance induite par deux antihistaminiques chez des patients traites en ambulatoire. Allergie Immunologie 9: 15–18
Huther KJ, Renftle G, Barraud N, Burke JT, Koch-Weser J (1977) Inhibitory activity of terfenadine on histamine-induced skin wheals in man. Eur J Clin Pharmacol 12: 195–199
Krnjevic KJ, Phyllis JW (1963) Actions of certain amines on cerebral cortical neurones. Br J Pharmacol 20: 471–490
Muler H, Blum F (1977) Essai compare de deux antihistaminiques: mequitazine et dexchlorpheniramine. Gaz Med Fr 84: 3–7
Netter KJ, Bodenschatz K (1967) Inhibition of histamine-N-methylation by some antihistamines. Biochem Pharmacol 16: 1627–1631
Nicholson AN (1979) Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man. Br J Clin Pharmacol 8: 321–324
Nicholson AN (1982) Antihistaminic activity and central effects of terfenadine. A review of European studies. Arzneimittelforsch 32: 1191–1193
Nicholson AN, Stone BM (1982) Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol 13: 199–202
Nicholson AN, Stone BM (1982) Hypnotic activity and effects on performance of lormetazepam and camazepam — analogues of temazepam. Br J Clin Pharmacol 13: 433–439
Nicholson AN, Smith PA, Spencer MB (1982) Antihistamines and visual function: Studies on dynamic visual acuity and the pupillary response to light. Br J Clin Pharmacol 14: 683–690
Orlando JP (1977) Utilisation du primalan dans une consultation d'allergologie respiratoire. J Agreges 10: 119–120
Quach TT, Duchemin AM, Rose C, Schwartz JC (1979) In vivo occupation of cerebral histamine H1-receptors evaluated with 3H-mepyramine may predict sedative properties of psychotropic drugs. Eur J Pharmacol 60: 391–392
Quach TT, Duchemin AM, Rose C, Schwartz JC (1980) Labeling of histamine H1-receptors in the brain of the living mouse. Neurosci Lett 17: 49–54
Reinberg A, Levi F, Guillet P, Burke JT, Nicolai A (1978) Chronopharmacological study of antihistamines in man with special reference to terfenadine. Eur J Clin Pharmacol 14: 245–252
Reinberg A, Bicakova-Rocher A, Peiffer C, Levi F, Nicolai A (1983) Effets de la mequitazine sur les rythmes circadiens des resultats de tests psychometriques et de la temperature orale. Eur J Clin Pharmacol (in press)
Uzan A, Le Fur G, Malogouris C (1979) Are antihistamines sedative via a blockade of brain H1-receptors? J Pharm Pharmacol 31: 701–702
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nicholson, A.N., Stone, B.M. The H1-antagonist mequitazine: Studies on performance and visual function. Eur J Clin Pharmacol 25, 563–566 (1983). https://doi.org/10.1007/BF00542129
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542129